Townsend Scott B

SVP, General Counsel at AMAG PHARMACEUTICALS, INC. · on record since Aug 16, 2012
VP OF LEGAL AFFAIRS AND SEC. at CORNERSTONE THERAPEUTICS INC · on record since Sep 16, 2004

Insider trading activity of Townsend Scott B

Transactions on record: 29; since Jan 24, 2005

Open-market buys: 0

Open-market sells: 3; $291.6K

Companies traded: 2; last filing Mar 5, 2015

Figures computed from official regulatory filings — .

Companies where Townsend Scott B has traded

AMAG PHARMACEUTICALS, INC.12 tx · $146.9K · Mar 5, 2015
CORNERSTONE THERAPEUTICS INC17 tx · $1M · May 18, 2009

Track record of Townsend Scott B

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Townsend Scott B

Co-insiders of Townsend Scott B

THOMAS FRANK EAMAG PHARMACEUTICALS, INC. +1
Adage Capital Advisors, L.L.C.AMAG PHARMACEUTICALS, INC.
ADAGE CAPITAL PARTNERS GP LLCAMAG PHARMACEUTICALS, INC.
ADAGE CAPITAL PARTNERS LPAMAG PHARMACEUTICALS, INC.
Advanced Technology Ventures VII(B), L.P.CORNERSTONE THERAPEUTICS INC
Advanced Technology Ventures VII(C), L.P.CORNERSTONE THERAPEUTICS INC
ADVANCED TECHNOLOGY VENTURES VII LPCORNERSTONE THERAPEUTICS INC
Advanced Technology Ventures VI, L.P.CORNERSTONE THERAPEUTICS INC
AGUIAR ERICCORNERSTONE THERAPEUTICS INC
ALLEN LEE F MD PhDAMAG PHARMACEUTICALS, INC.
Apps Charles DavidAMAG PHARMACEUTICALS, INC.
Arkowitz DavidAMAG PHARMACEUTICALS, INC.
ARMISTICE CAPITAL, LLCAMAG PHARMACEUTICALS, INC.
Armistice Capital Master Fund Ltd.AMAG PHARMACEUTICALS, INC.
Atchinson RobertAMAG PHARMACEUTICALS, INC.
ATV Alliance 2003, L.P.CORNERSTONE THERAPEUTICS INC
ATV Alliance Associates, L.L.C.CORNERSTONE THERAPEUTICS INC
ATV Associates VII, L.L.C.CORNERSTONE THERAPEUTICS INC
ATV Associates VI, L.L.C.CORNERSTONE THERAPEUTICS INC
ATV Entrepreneurs VII, L.P.CORNERSTONE THERAPEUTICS INC
ATV Entrepreneurs VI, L.P.CORNERSTONE THERAPEUTICS INC
AVALLONE MICHAEL NAMAG PHARMACEUTICALS, INC.
Baldwin Chenyqua MicheleCORNERSTONE THERAPEUTICS INC
BIOTECHNOLOGY VALUE FUND II LPAMAG PHARMACEUTICALS, INC.
BIOTECHNOLOGY VALUE FUND L PAMAG PHARMACEUTICALS, INC.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
AMAG PHARMACEUTICALS, INC.Listing unverified	Mar 5, 2015	Other	-831	49.70 USD	$41.3K		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Feb 27, 2015	Award	5,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Feb 27, 2015	AwardD (derivative)	10,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Dec 18, 2014	Other	-1,789	40.49 USD	$72.4K	Unusual size	SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Aug 21, 2014	Award	15,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Aug 21, 2014	Award	5,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Feb 28, 2014	AwardD (derivative)	30,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Feb 28, 2014	Award	5,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Dec 17, 2013	Other	-1,429	23.23 USD	$33.2K	Unusual size	SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Mar 4, 2013	Award	7,500	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Mar 4, 2013	Award	4,400	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Mar 4, 2013	AwardD (derivative)	26,300	—	n/a (No price was disclosed in the filing)		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	May 18, 2009	Sell	-5,600	6.50	$36.4K		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	May 18, 2009	Sell	-13,000	6.63	$86.2K		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	May 18, 2009	Sell	-26,372	6.41	$169K		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Nov 4, 2008	Other	-193	3.90	$752.7		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Nov 4, 2008	Award	148,722	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Feb 19, 2008	Award	35,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Dec 28, 2007	Other	-4,270	1.28	$5.5K		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Nov 7, 2007	Award	25,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Jun 4, 2007	Other	11,438	1.59	$18.2K		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Mar 19, 2007	AwardD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Dec 29, 2006	AwardD (derivative)	25,000	—	n/a (No price was disclosed in the filing)		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Dec 29, 2006	Award	26,700	26.70	$712.9K		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Jun 27, 2006	AwardD (derivative)	50,000	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
AMAG PHARMACEUTICALS, INC.Listing unverified	Mar 5, 2015	Other	-831	49.70 USD	$41.3K		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Feb 27, 2015	Award	5,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Feb 27, 2015	AwardD (derivative)	10,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Dec 18, 2014	Other	-1,789	40.49 USD	$72.4K	Unusual size	SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Aug 21, 2014	Award	15,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Aug 21, 2014	Award	5,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Feb 28, 2014	AwardD (derivative)	30,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Feb 28, 2014	Award	5,000	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Dec 17, 2013	Other	-1,429	23.23 USD	$33.2K	Unusual size	SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Mar 4, 2013	Award	7,500	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Mar 4, 2013	Award	4,400	—	n/a (No price was disclosed in the filing)		SEC
AMAG PHARMACEUTICALS, INC.Listing unverified	Mar 4, 2013	AwardD (derivative)	26,300	—	n/a (No price was disclosed in the filing)		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	May 18, 2009	Sell	-5,600	6.50	$36.4K		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	May 18, 2009	Sell	-13,000	6.63	$86.2K		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	May 18, 2009	Sell	-26,372	6.41	$169K		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Nov 4, 2008	Other	-193	3.90	$752.7		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Nov 4, 2008	Award	148,722	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Feb 19, 2008	Award	35,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Dec 28, 2007	Other	-4,270	1.28	$5.5K		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Nov 7, 2007	Award	25,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Jun 4, 2007	Other	11,438	1.59	$18.2K		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Mar 19, 2007	AwardD (derivative)	40,000	—	n/a (No price was disclosed in the filing)		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Dec 29, 2006	AwardD (derivative)	25,000	—	n/a (No price was disclosed in the filing)		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Dec 29, 2006	Award	26,700	26.70	$712.9K		SEC
CORNERSTONE THERAPEUTICS INCListing unverified	Jun 27, 2006	AwardD (derivative)	50,000	—	n/a (No price was disclosed in the filing)		SEC